- Home
- GF vs OPRX Comparison
GF vs OPRX Comparison
Compare GF & OPRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GF
- OPRX
- Stock Information
- Founded
- GF 1990
- OPRX 2006
- Country
- GF Germany
- OPRX United States
- Employees
- GF N/A
- OPRX N/A
- Industry
- GF Investment Managers
- OPRX Business Services
- Sector
- GF Finance
- OPRX Consumer Discretionary
- Exchange
- GF Nasdaq
- OPRX Nasdaq
- Market Cap
- GF 155.4M
- OPRX 154.9M
- IPO Year
- GF N/A
- OPRX N/A
- Fundamental
- Price
- GF $12.01
- OPRX $12.97
- Analyst Decision
- GF
- OPRX Buy
- Analyst Count
- GF 0
- OPRX 8
- Target Price
- GF N/A
- OPRX $10.81
- AVG Volume (30 Days)
- GF 28.1K
- OPRX 221.5K
- Earning Date
- GF 01-01-0001
- OPRX 08-07-2025
- Dividend Yield
- GF 0.82%
- OPRX N/A
- EPS Growth
- GF N/A
- OPRX N/A
- EPS
- GF N/A
- OPRX N/A
- Revenue
- GF N/A
- OPRX $94,365,000.00
- Revenue This Year
- GF N/A
- OPRX $14.44
- Revenue Next Year
- GF N/A
- OPRX $10.63
- P/E Ratio
- GF N/A
- OPRX N/A
- Revenue Growth
- GF N/A
- OPRX 20.66
- 52 Week Low
- GF $7.38
- OPRX $3.78
- 52 Week High
- GF $9.41
- OPRX $15.71
- Technical
- Relative Strength Index (RSI)
- GF 51.70
- OPRX 48.21
- Support Level
- GF $11.84
- OPRX $12.24
- Resistance Level
- GF $12.47
- OPRX $14.96
- Average True Range (ATR)
- GF 0.13
- OPRX 0.80
- MACD
- GF -0.04
- OPRX -0.05
- Stochastic Oscillator
- GF 18.31
- OPRX 26.84
About GF New Germany Fund Inc. (The)
NEW GERMANY FUND INC is a non-diversified, closed-end management investment company. As the investment objective, the fund seeks long-term capital appreciation through investment in middle-market German equities. The fund's portfolio of investment includes investments in different sectors such as the industrials, information technology, material, consumer discretionary, Communication Services, Financials, Consumer Staples, Real Estate, Utilities, Healthcare, Energy, and others. Its portfolio is geographically diversified across the Netherlands, Germany, and Luxembourg.
About OPRX OptimizeRx Corporation
OptimizeRx Corp is engaged in the healthcare market in the United States. It provides digital health messaging via electronic health records, providing a direct channel for pharmaceutical companies to communicate with healthcare providers and patients. The cloud-based solution supports patient adherence to medications by providing real-time access to financial assistance, prior authorization, education, and clinical information. Its product offerings are Financial Messaging, Brand and Clinical Messaging, Brand Support, and Patient Engagement.